Received: 6 July 2020
Revised: 31 August 2020
Accepted: 3 September 2020
First Online: 18 September 2020
Compliance with ethical standards
: Dr. Pickhardt serves is an advisor to Bracco and Zebra and is a shareholder in SHINE, Elucent, and Cellectar; Dr. Summers receives royalties from iCAD, PingAn, Philips, ScanMed and Translation Holdings, and research support from PingAn (CRADA) and NVIDIA (GPU card donations).